ARCHIVES

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

June 24, 2005

NCI Bypass Budget Seeks $1 Billion Increase For FY 2011

February 26, 2010

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

Abstracts From AACR Annual Meeting

June 4, 1976

Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted

September 6, 1974

NCI’s Frei & Freireich era Lauded As Researchers Receive First NIH Distinguished Alumni Award

September 14, 1990